Granulocyte and monocyte adsorption apheresis (GCAP) for refractory skin diseases caused by activated neutrophils and psoriatic arthritis: Evidence that GCAP removes Mac-1-expressing neutrophils

Therapeutic Apheresis and Dialysis

Volumn 10, Issue 3, 2006, Pages 247-256

  Kanekura, Takuro ^a   Hiraishi, Katsuya ^b   Kawahara, Koichi ^a   Maruyama, Ikuro ^a   Kanzaki, Tamotsu ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

Author keywords

Adsorptive apheresis; Arthritis; Complement; Mac 1; Neutrophilic dermatosis

Indexed keywords

CD11B ANTIGEN; CELLULOSE ACETATE; EDETIC ACID; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD11B; UNCLASSIFIED DRUG;

ADSORPTION; ADULT; AGED; APHERESIS; ARTHROPATHY; ARTICLE; BLOOD CELL; CLINICAL ARTICLE; FEMALE; GRANULOCYTE; GRANULOCYTE AND MONOCYTE ADSORPTION APHERESIS; HUMAN; MALE; NEUTROPHIL; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; SKIN DISEASE;

ADSORPTION; ADULT; AGED; ARTHRITIS, PSORIATIC; CELLULOSE; FEMALE; GRANULOCYTES; HEMOPERFUSION; HUMANS; LEUKAPHERESIS; MACROPHAGE-1 ANTIGEN; MALE; MIDDLE AGED; MONOCYTES; NEUTROPHIL INFILTRATION; PILOT PROJECTS; PYODERMA; TREATMENT OUTCOME;

EID: 33745558583     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2006.00369.x     Document Type: Article

References (22)

1. Saniabadi AR, Hanai H, Takeuchi K et al. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther Apher Dial 2003;7:48-59.
2. Hiraishi K, Takeda Y, Shiobara N et al. Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorption apheresis. Ther Apher Dial 2003;7:334-40.
3. Sawada K, Ohnishi K, Kosaka T et al. Leukocytapheresis therapy with leukocyte removal filter for inflammatory bowel disease. J Gastroenterol 1995;30:124-7.
4. Shimoyama T, Sawada K, Hiwatashi N et al. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apheresis 2001;16:1-9.
5. Hanai H, Watanabe F, Takeuchi K et al. Leukocyte adsorption apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol 2003;1:28-35.
6. Callen JP. Pyoderma gangrenosum. Lancet 1998;351:581-5.
7. Kanekura T, Maruyama I, Kanzaki T. Granulocyte and monocyte adsorption apheresis for pyoderma gangrenosum. J Am Acad Dermatol 2002;47:320-1.
8. Kanekura T, Yoshii N, Yonezawa T, Kawabata H, Saruwatari H, Kanzaki T. Treatment of pustular psoriasis with granulocyte and monocyte adsorption apheresis. J Am Acad Dermatol 2003;49:329-32.
9. Kanekura T, Kawabata H, Maruyama I, Kanzaki T. Treatment of psoriatic arthritis with granulocyte and monocyte adsorption apheresis. J Am Acad Dermatol 2004;50:242-6.
10. Kanekura T, Hashiguchi T, Mera Y et al. Improvement of SLE skin rash with granulocyte and monocyte adsorption apheresis. Dermatology 2004;208:79-80.
11. Kanekura T, Terasaki K, Higashi Y et al. Improvement of adult Still's disease with granulocyte and monocyte adsorption apheresis. Clin Exp Dermatol 2004;29:410-12.
12. Kanekura T, Gushi A, Iwata M et al. Treatment of Behcet's disease with granulocyte and monocyte adsorption apheresis. J Am Acad Dermatol 2004;51:S83-7.
13. Kanekura T, Mochitomi Y, Fujimoto S, Kawahara K, Maruyama I, Kanzaki T. Granulocyte and monocyte adsorption apheresis for leg ulcers in a patient with rheumatoid arthritis. J Am Acad Dermatol 2005;52:1108-9.
14. Diamond MS, Springer TA. A subpopulation of Mac-1 (CD11b:/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J Cell Biol 1993;120:545-56.
15. Corbi AL, Kishimoto TK, Miller LJ, Springer TA. The human leukocyte adhesion glycoprotein Mac-1 (complement receptor type 3, CD11b) alpha subunit. Cloning, primary structure, and relation to the integrins, von Willebrand factor and factor B. J Biol Chem 1988;263:12403-11.
16. Arnaout MA, Gupta SK, Pierce MW, Tenen DG. Amino acid sequence of the alpha subunit of human leukocyte adhesion receptor Mo1 (complement receptor type 3). J Cell Biol 1988;106:2153-8.
17. Beller DI, Springer TA, Schreiber RD. Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor. J Exp Med 1982;156:1000-9.
18. Cai TQ, Wright SD. Human leukocyte elastase is an endogenous ligand for the integrin CR3 (CD11b/CD18. Mac-1, alpha M beta 2) and modulates polymorphonuclear leukocyte adhesion. J Exp Med 1996;184:1213-23.
19. Cheung AK, Hohnholt M, Gilson J. Adherence of neutrophils to hemodialysis membranes: role of complement receptors. Kidney Int 1991;40:1123-33.
20. Weinstein GD, Koo JY, Krueger GG, Lebwohl MG, Lowe NJ, Menter MA. Lew-Kaya DA, Sefton J, Gibson JR, Walker PS, Tazarotene Cream Clinical Study Group. Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks. J Am Acad Dermatol 2003;48:760-7.
21. Nagashima M, Yoshino S, Tanaka H, Yoshida N, Kashiwagi N, Saniabadi AR. Granulocyte and monocyte apheresis suppresses symptoms of rheumatoid arthritis: a pilot study. Rheumatol Int 1998;18:113-18.
22. Takeda Y, Shiobara N, Saniabadi AR, Adachi M, Hiraishi K. Adhesion dependent release of hepatocyte growth factor and interleukin-1 receptor antagonist from human blood granulocytes and monocytes: Evidence for the involvement of plasma IgG. complement C3 and β2 integrin. Inflamm Res 2004;53:277-83.